Maricann Group (CSE:MARI) announced its subsidiary obtained an export permit from Health Canada for the shipment of dried cannabis flower to Germany.
As quoted in the press release:
This is the first export permit that Maricann has received.
Ben Ward, CEO Stated, “This export permit marks another milestone in the Company’s history and an important first, as we continue to build our Company, globally. Our team of regulatory experts, led by VP of Regulatory Affairs, Dr. Alexandre Sibilev in Canada, continues to add value for Maricann shareholders through this and previous successes, demonstrating a solid track record in moving through regulatory processes.
The Company is established in Germany, with operations for its two 95 [percent] owned subsidiaries, Maricann GmbH (THC cannabis) and Mariplant GmbH (non-THC cannabis) centred at its campus in Ebersbach, Germany (between Leipzig and Dresden).
Click here to read the full press release.
The post Maricann Gets Export Permit to Germany from Health Canada appeared first on Investing News Network.